Application Value of Glucocorticoid in the Treatment of Early Bronchopulmonary Dysplasia

Affiliated Hospital of Southwest Medical University; Sichuan Luzhou; China

doi:10.13407/ j.cnki.jpp.1672.108X.2022.04.013

您当前的位置：

首页 >

文章列表页 >

Application Value of Glucocorticoid in the Treatment of Early Bronchopulmonary Dysplasia

更新时间：2022-11-03

- Application Value of Glucocorticoid in the Treatment of Early Bronchopulmonary Dysplasia
- Vol. 28, Issue 4, Pages: 44-48(2022)
- 作者机构：
  
  西南医科大学附属医院,四川,泸州,646000
- 作者简介：
- 基金信息：
- DOI：10.13407/ j.cnki.jpp.1672.108X.2022.04.013
  CLC：
- Published：2022，
扫描看全文
Affiliated Hospital of Southwest Medical University, Sichuan Luzhou, China. Application Value of Glucocorticoid in the Treatment of Early Bronchopulmonary Dysplasia. [J]. 28(4):44-48(2022)
DOI：

Affiliated Hospital of Southwest Medical University, Sichuan Luzhou, China. Application Value of Glucocorticoid in the Treatment of Early Bronchopulmonary Dysplasia. [J]. 28(4):44-48(2022) DOI： 10.13407/ j.cnki.jpp.1672.108X.2022.04.013.

摘要

目的:探讨应用糖皮质激素治疗早期支气管肺发育不良(BPD)的疗效及安全性。方法:回顾性分析2016 年1 月至2019 年7 月入住我院

胎龄臆30 周且体质量臆1 500 g

生后28 d 不能撤离无创呼吸机和(或)脱氧的早期BPD 患儿住院资料。按使用药物分为地塞米松(DXM)组24 例、氢化可的松(HC)组37 例及对照组50 例。对照组患儿早期接受咖啡因预防呼吸暂停、限制液体量、呼吸支持、营养支持、存在感染时使用抗生素等常规治疗;HC 组在常规治疗基础上给予氢化可的松琥珀酸钠

疗程 10 d;DXM 组在常规治疗基础上给予地塞米松磷酸钠注射液

疗程9 d。比较三组患儿的围产期因素、治疗过程及临床结局情况。结果:与对照组相比

DXM 组和HC 组患儿出生体质量较低

胎龄较小(P 均<0.05)。矫正胎龄36 周时

三组BPD 比例比较差异无统计学意义(P 均>0.05)

但DXM 组总用氧时间短于对照组和HC 组(P 均<0.05)。结论:使用DXM 或HC 治疗早期 BPD 不能有效降低矫正胎龄36 周时中重度BPD 的比例

但应用DXM 缩短了BPD 患儿的用氧时间。

Abstract

Objective: To explore the efficacy and safety of glucocorticoid in the treatment of early bronchopulmonary dysplasia (BPD). Methods: Clinical data of inpatients with early BPD admitted into our hospital from Jan. 2016 to Jul. 2019

gestational age 燮30 weeks and body weight 燮1

500 g

who could not be withdraw from non鄄invasive ventilator and/ or deoxygenation at 28th day after birth were retrospectively analyzed. All patients were divided into 24 cases in the dexamethasone (DXM) group

37 cases in the hydrocortisone (HC) group and 50 cases in the control group according to different treatment regimens. The control group received conventional treatment such as caffeine for apnea prevention

fluid restriction

respiratory support

nutritional support and antibiotics for infection. The HC group was given hydrocortisone sodium succinate on the basis of conventional treatment for 10 d. The DXM group was treated with dexamethasone sodium phosphate injection on the basis of the conventional treatment for 9 d. The perinatal factors

treatment process and clinical outcomes of three groups were compared. Results: Compared with the control group

the DXM group and HC group had lower birth weight and smaller gestational age (P<0.05). At 36 weeks of postmenstrual age

there was no significant difference in the proportion of BPD among three groups (P>0.05)

yet the total oxygen consumption time in the DXM group was shorter than that in the control group and the HC group (P<0.05). Conclusion: Treatment of early BPD with DXM or HC was not effective in reducing the rate of moderate to severe BPD at 36 weeks of postmenstrual age

yet application of DXM shortens the total oxygen consumption time in children with BPD.

关键词

支气管肺发育不良地塞米松氢化可的松早产儿低出生体质量儿

Keywords

bronchopulmonary dysplasiaexamethasonehydrocortisonepreterm infantslow birth weight infants

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Risk Factors for Bronchopulmonary Dysplasia Complicated with Pulmonary Hypertension in Preterm Infants

Comparison of Efficacy and Safety of Dexamethasone Versus Methylprednisolone in the Treatment ofChildren with Refractory Mycoplasma Pneumoniae Pneumonia

Pharmaceutical Care for a Case of Extremely Low Birth Weight Preterm Infant with Metabolic Bone Disease by Clinical Pharmacists

Effects of Pulmonary Surfactant on Cerebral Oxygen Metabolism in Preterm Infants

Clinical Characteristics and Risk Factors of Necrotizing Enterocolitis in Term Infants and Preterm Infants

Related Author

Yue Weihong

Yu Jialin

Yin Zhanru

Ma Zhongzheng

Lyu Xiaoqian

Song Shiqing

Gao Rongrong

He Yang

Related Institution

Children’s Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing Key Laboratory of Pediatrics

Hengshui People’ sHospital, Hebei Hengshui

Shenzhou People’s Hospital, Hebei Shenzhou

National Children’s Medical Center, Children’s Hospital of Fudan University

Children’s Hospital of Yuxi, Yunan Yuxi

⁰